[Propranolol in the control of arterial hypertension in patients with chronic renal insufficiency]. 1975

J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea
January 1966, Minerva nefrologica,
J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea
January 1995, La Revue de medecine interne,
J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea
November 1978, Revue medicale de la Suisse romande,
J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea
January 1989, La Pediatria medica e chirurgica : Medical and surgical pediatrics,
J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea
January 1985, Clinical nephrology,
J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea
May 1986, Scandinavian journal of clinical and laboratory investigation,
J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea
October 2007, Nephrologie & therapeutique,
J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea
June 1953, Revue medicale de la Suisse romande,
J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea
January 1979, Therapie,
J L De Sancho, and R Muñíz, and P Gómez-Ullate, and L Orofino, and F Villar, and I Lampreabe, and R García Damborenea
July 1971, Prensa medica argentina,
Copied contents to your clipboard!